Alben Chemicals Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 1.48 M
- Company Age 29 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 6.50 M
- Revenue Growth 57.62%
- Profit Growth 63.90%
- Ebitda 122.55%
- Net Worth 31.05%
- Total Assets 15.68%
About Alben Chemicals
Alben Chemicals Private Limited (ACPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 08 June 1995 and has a history of 29 years and eight months. Its registered office is in Central Delhi, Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.48 M.
The company has closed loans amounting to ₹6.50 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Ravindra Singh and Maninder Kaur serve as directors at the Company.
Company Details
- Location
Central Delhi, Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74899DL1995PTC069576
- Company No.
069576
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Jun 1995
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Alben Chemicals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ravindra Singh  | Director | 08-Jun-1995 | Current |
| Maninder Kaur | Director | 22-Nov-2015 | Current |
Financial Performance of Alben Chemicals.
Alben Chemicals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 57.62% increase. The company also saw a substantial improvement in profitability, with a 63.9% increase in profit. The company's net worth Soared by an impressive increase of 31.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Alben Chemicals?
In 2023, Alben Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹6.50 M
Charges Breakdown by Lending Institutions
- Punjab National Bank : 0.65 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Dec 2011 | Punjab National Bank | ₹5.00 M | Satisfied |
| 25 Apr 2006 | Punjab National Bank | ₹1.10 M | Satisfied |
| 17 Feb 2003 | Punjab National Bank | ₹0.40 M | Satisfied |
How Many Employees Work at Alben Chemicals?
Unlock and access historical data on people associated with Alben Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alben Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alben Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
